Articles Published in 2011

Agios raises $78 million in financing

Thursday, November 17, 2011 11:18 AM

Agios Pharmaceuticals has secured $78 million in an oversubscribed Series C financing. The proceeds of this financing will be used to advance the company's rapidly emerging portfolio of cancer metabolism therapeutics into the clinic and to expand research and development into inborn errors of metabolism (IEMs), a group of genetic disorders with high unmet medical need.

More... »

Cardica enrolls first patients in MicroCutter study

Thursday, November 17, 2011 11:09 AM

Cardica has enrolled the first patients and discharged from the first two investigative sites in a European clinical study to evaluate its MicroCutter surgical cutting/stapling devices for transections, resections and anastomoses during gastrointestinal surgical procedures.

More... »

UCB enters strategic partnerships with Parexel and PRA

Thursday, November 17, 2011 10:33 AM

Brussels, Belgium-based UCB has entered into strategic partnerships with Parexel and PRA to drive UCB’s operational clinical development activities. The agreements are effective for all of UCB’s new clinical study programs on a global basis.

More... »

Allena Pharmaceuticals secures $15 million in Series A financing

Wednesday, November 16, 2011 03:03 PM

Allena Pharmaceuticals, a company developing and commercializing innovative non-systemic oral protein therapeutics, has secured $15 million in Series A venture capital financing. Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures led the round. Proceeds from the financing will be used to accelerate the development of Allena's non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

More... »

Bend Research signs licensing agreement with Merck

Wednesday, November 16, 2011 02:49 PM

Bend Research, an independent drug-formulation development and manufacturing company, has entered into a licensing agreement with Merck, through a subsidiary.

More... »

Genzyme, Cystic Fibrosis Foundation Therapeutics ink research agreement

Wednesday, November 16, 2011 02:33 PM

Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics, the nonprofit affiliate of the Cystic Fibrosis Foundation, have signed a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.

More... »

Theorem names VP, EMEA

Wednesday, November 16, 2011 02:19 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Christian Tucat vice president & general manager, Europe Middle East & Africa. In this role, Tucat will have direct accountability for sales and the P&L of Theorem’s business in these regions.

More... »

INC Research, SAS collaborate to improve clinical development

Wednesday, November 16, 2011 01:59 PM

INC Research and SAS are working together to improve clinical development risk management and achieve targeted product profiles through analytics. Collaborating with SAS, INC Research will offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency and flexibility. The ultimate goal is to improve a customer’s ability to manage risk, control investment and maximize ROI in clinical development.

More... »

Fujifilm, Kyowa Kakko Kirin partner to develop biosimilars

Wednesday, November 16, 2011 01:46 PM

FUJIFILM and Kyowa Hakko Kirin have reached a basic agreement to establish a joint venture in the spring of 2012 to develop highly reliable, high-quality and competitive products in the fast-growing biosimilars market.

More... »

ICON's DOCS expands with four new offices in Europe

Wednesday, November 16, 2011 10:11 AM

ICON's resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.

More... »

CenterWatch Data Library



Browse by:


December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs